Menu utilisateur

Accès à distance ? S'identifier sur le proxy UCLouvain

Rechercher

Affichage: 9 résultats.
    • Article de périodique
    Non-infusional vs intravenous consolidation chemotherapy in elderly patients with acute myeloid leukemia: final results of the EORTC-GIMEMA AML-13 randomized phase III trial
    Jehn, U. Suciu, Stefan[UCL] Thomas, X. Lefrere, F. Muus, P. Berneman, Z. Marie, J-P Adamo, F. Fillet, G. Nobile, F. Ricciuti, F. Leone, G. Rizzoli, V. Montanaro, M. Beeldens, F. Fazi, P. Mandelli, F. Willemze, R. de Witte, T. Amadori, S. (2006) Leukemia — Vol. 20, no. 10, p. 1723-1730 (2006)
    • Communication
    Allogeneic SCT planned in CR-1 after intensive chemotherapy in patients with bad prognosis MDS results in better outcome in the intermediate/high-risk cytogenetic group: a study by the EORTC, EBMT, SAKK, HOVON and GIMEMA Leukemia Groups
    de Witte, T. Hagemeijer, Anne Suciu, Stefan[UCL] Belhabri, A Delforge, Michel Aul, C Aivado, M Selleslag, D. Schouten, H Ferrant, Augustin[UCL] Biersack, H Amadori, S. Muus, P. Jehn, U. Beeldens, F. Jansen, J Hellstrom-Lindberg, P Ossenkoppele, G Gratwohl, A. Marie, JP Willemze, R. (2006) 32nd Annual Meeting of the European-Group-for-Blood-and-Morrow-Transplantation/22nd Meeting of the EBMT-Nures-Group/5th Meeting of the EMBT-Data-Management-Group — Hamburg (Germany)
    • Article de périodique
    The presence of an HLA-identical sibling donor has no impact on outcome of patients with high-risk MDS or secondary AML (sAML) treated with intensive chemotherapy followed by transplantation: results of a prospective study of the EORTC, EBMT, SAKK and GIMEMA Leukemia Groups (EORTC study 06921)
    Oosterveld, M Ferrant, Augustin[UCL] Suciu, Stefan[UCL] Verhoef, G. Labar, B. Belhabri, A Aul, C Selleslag, D. Wijermans, P Mandelli, F. Amadori, S. Jehn, U. Muus, P. Zittoun, R Hess, U. Anak, O Beeldens, F. Willemze, R. de Witte, T. (2003) Leukemia — Vol. 17, no. 5, p. 859-868 (2003)
    • Article de périodique
    Chemotherapy only compared to chemotherapy followed by transplantation in high risk myelodysplastic syndrome and secondary acute myeloid leukemia; two parallel studies adjusted for various prognostic factors
    Oosterveld, M Ferrant, Augustin[UCL] Muus, P. Suciu, Stefan[UCL] Koller, C Verhoef, G. Labar, B. Wijermans, P Aul, C Fiere, D. Selleslag, D. Willemze, R. Gratwohl, A. Mandelli, F. Cortes, J de Witte, T. Estey, E (2002) Leukemia — Vol. 16, no. 9, p. 1615-1621 (2002)
    • Communication
    Improvement in Fatigue With Eculizumab Treatment of Patients With Paroxysmal Nocturnal Hemoglobinuria (pnh) Occurs Independent of Changes in Anemia
    Hill, A. Van Den Neste, Eric[UCL] Muus, P. Duehrsen, U. Socie, G. Risitano, A. De Paz, R. Zanella, A. Lai, J. S. Hillmen, P. Rother, R. Cella, D. (2008) 13th Congress of the European-Hematology-Association — Copenhagen (Denmark)
    • Communication
    Intensive chemotherapy versus autologous or allogeneic stemcell transplantation for the treatment of patients with poor risk MDS and secondary AML-A joint study of the Eortc, Ebmt, Hovon, Swiss, Scandinavian and Gimema leukemia groups: A biomed-2 EU-project.
    deWitte, TM Ferrant, Augustin[UCL] Suciu, Stefan[UCL] Anak, O Hagemeijer, Anne[UCL] Selleslag, D. Delforge, Michel[UCL] Belhabi, A Schouten, H Gratwohl, A. Aul, C Aivado, M Amadori, S. Muus, P. Tigaud, I. Jotterand-Bellomo, M Willemze, R. (1999) —
    • Article de périodique
    Intensive chemotherapy followed by allogeneic or autologous stem cell transplantation for patients with myelodysplastic syndromes (MDSs) and acute myeloid leukemia following MDS
    de Witte, T. Ferrant, Augustin[UCL] Suciu, Stefan[UCL] Verhoef, G. Labar, B. Archimbaud, E. Aul, C Selleslag, D. Wijermans, P Mandelli, F. Amadori, S. Jehn, U. Muus, P. Boogaerts, M. Zittoun, R Gratwohl, A. Zwierzina, H Hagemeijer, Anne[UCL] Willemze, R. (2001) Blood — Vol. 98, no. 8, p. 2326-2331 (2001)
    • Communication
    Comparison of quality of life (QOL) of patients with acute myelogenous leukemias (AML) in long-term first complete remission (CR) after bone marrow transplantation (BMT) - Allogeneic or autologous - Or intensive chemotherapy consolidation (ICC): EORTC-GIMEMA AML 8A study
    Zittoun, R Suciu, Stefan[UCL] Solbu, G Watson, M. Muus, P. Mandelli, F. Stryckmans, P. Peetermans, M Thaler, J Willemze, R. (1995) —
    • Communication
    The clinical benefit of eculizumab is demonstrable in all subpopulations of patients with paroxysmal nocturnal hemoglobinuria (PNH) with hemolysis
    Muus, P. Van Den Neste, Eric[UCL] Duehrsen, U. Elebute, M. Browne, P. Urbano-Ispizua, A. Coutre, S. De Paz, R. Konkle, B. Moskovits, T. Nakamura, R. Zanella, A. Hillmen, P. Rother, R. P. Soci, G. (2007) 12th Congress of the European-Hematology-Association — Vienna (Austria)